Clinical trial
TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT00036920 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00036920 |
|---|---|
| Title | TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer |
| Official title | Phase II Study Of TLK286 For The Treatment Of Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | canfosfamide hydrochloride |
| Start date | Jan 1, 2002 |
| Primary completion | Aug 1, 2002 |
| Completion | Dec 1, 2009 |
| First posted | Nov 21, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: